A Case of Non Seminatous Germ Cell tumour of the Testes with Very Late Relapse
Abstract
Non seminomatous germ cell tumors are known to have excellent response to modern
cisplatin-based chemotherapy and or appropriate surgery, early-stage testicular cancer has a cure
rate of 95 to 100 percent, whereas advanced disease has a 70 percent cure rate. However, up to 10
percent of patients who achieve a disease-free status with initial chemotherapy will eventually
relapse, with majority of them relapsing within first 2 years of completion of treatment. Late relapses,
after 2 years are seen with Seminoma but late relapse with NSGCT are relatively rare, with relapse
rates ranging from 1-6 percent described in literature. We are reporting a very late relapse of NSGCT,
after eighteen years of treatment.
Full Text:
PDFReferences
David W. George, Richard S. Foster, et al: Update on Late Relapse of Germ Cell Tumor: A Clinical
and Molecular Analysis, J Clin Oncol 2003 21:113-122.
Oldenburg J, Fossa SD: Late relapse of nonseminomatous germ cell tumors: BJU Int. 2009 Nov;
(9 Part B):1413-7.
Sheinfeld J, Motzer RJ, Rabbani F, et al: Incidence and clinical outcome of patients with teratoma
in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and
IIA nonseminomatous germ cell tumors. J Urol 170:1159-1162, 2003.
Baniel J, Foster RS, Gonin R, et al: Late relapse of testicular cancer. J Clin Oncol 13: 1170-1176,
11. DeLeo MJ, Greco FA, Hainsworth JD, et al: Late recurrences in long-term survivors of germ
cell neoplasms. Cancer 62:985-988, 1988
DeLeo MJ, Greco FA, Hainsworth JD, et al: Late recurrences in long-term survivors of germ cell
neoplasms. Cancer 62:985-988, 1988
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University